S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

José Luis Marín‐Rubio(Memorial Sloan Kettering Cancer Center), María Villa‐Morales(Centre for Biomedical Network Research on Rare Diseases)

Carcinogenesis

February 22, 2019

10.1093/carcin/bgz041

Cited by 18

Related Papers

FAS system deregulation in T-cell lymphoblastic lymphoma

|Cell Death and Disease|2014|17

Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas , FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility

|Carcinogenesis|2010|14